Author details

Full Name

Xiaohang Zhao

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36670112	BACH1-induced ferroptosis drives lymphatic metastasis by repressing the biosynthesis of monounsaturated fatty acids.		2023
35894387	MARCKSL1 interacted with F-actin to promote esophageal squamous cell carcinoma mobility by modulating the formation of invadopodia.	Cancer Medicine	2023
37337648	Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.		2023
37209815	In-Depth Serum Proteomics Reveals the Trajectory of Hallmarks of Cancer in Hepatitis B Virus-Related Liver Diseases.		2023
36709122	[The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].		2023
34958892	Tumor-stroma TGF-Î²1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin Î±Î²/CD36-mediated activation of the MAPK pathway.	Cancer Letters	2022
35589723	Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis.	Nature Communications	2022
35384341	Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma.	Clinical and Translational Medicine	2022
35945453	Forming cytoplasmic stress granules PURÎ± suppresses mRNA translation initiation of IGFBP3 to promote esophageal squamous cell carcinoma progression.	Oncogene	2022
35004946	Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice.		2021
34062216	Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.	Cancer Letters	2021
34166767	Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy.	Cancer Letters	2021
33932125	BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.	Cancer Medicine	2021
34034471	[Effect of RNF152 on NO induced apoptosis of colon cancer cells].	Chinese Journal of Oncology	2021
33144099	PURÎ± mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.	Cancer Letters	2021
32617296	Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.	Annals of Translational Medicine (discontinued)	2020
33142842	PURÎ± Promotes the Transcriptional Activation of in Oesophageal Squamous Cell Carcinoma Cells.	Genes	2020
31356194	Role of Smac, survivin, XIAP, and Omi/HtrA2 proteins in determining the chemotherapeutic response of patients with cervical cancer treated with neoadjuvant chemotherapy.	Cancer Biomarkers	2019
31572066	Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.	Cancer Cell International	2019
30530815	miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.	Cancer Res	2019
31354222	Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.	Chinese Journal of Cancer Research (discontinued)	2019
29577639	A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.	Cancer Medicine	2018
29331417	Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.	Cancer Letters	2018
29408653	Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma.	Cancer Letters	2018
28316214	[Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].	Chinese Journal of Oncology	2017
28424552	Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.	OncoTargets and Therapy	2017
28977901	Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma.	Oncotarget	2017
28440066	Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.	Cancer Medicine	2017
29024941	In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.	Br J Cancer	2017
29209147	Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression.	Int J Biol Sci	2017
28220687	Environmental factors, seven GWAS-identified susceptibility loci, and risk of gastric cancer and its precursors in a Chinese population.	Cancer Medicine	2017
27621578	Protein and gene expression characteristics of heterogeneous nuclear ribonucleoprotein H1 in esophageal squamous cell carcinoma.		2016
28914036	[Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome].	Zhongguo Zhongyao Zazhi	2016
26934124	The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.	Oncotarget	2016
27414086	NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.	Cancer Biology and Therapy	2016
26783832	Correction to "Biomarker Discovery and Verification of Esophageal Squamous Cell Carcinoma Using Integration of SWATH/MRM".	J Proteome Res	2016
27216119	Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.	Sci Rep	2016
26993605	Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.	Oncotarget	2016
27312428	A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer.	Sci Rep	2016
27030498	[Expression and clinical significance of ELOVL6 gene in high-grade serous ovarian carcinoma].	Zhonghua fu chan ke za zhi	2016
26167094	Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.		2015
25799539	SELEX aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients.	PLoS ONE	2015
26478675	Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.		2015
26224564	Biomarker Discovery and Verification of Esophageal Squamous Cell Carcinoma Using Integration of SWATH/MRM.	J Proteome Res	2015
26090615	YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice.	Oncotarget	2015
25138052	Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-ÎºB pathways with novel theanine derivatives.	Oncotarget	2014
25400784	Influence of Per3 genotypes on circadian rhythmicity in flight cadets after militarized management.	International Journal of Clinical and Experimental Pathology (discontinued)	2014
25345008	[Recent advance in high accuracy iTRAQ for quantitative proteomics].	Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology	2014
25720159	[Short gel method for pretreatment of protein samples with high concentration of detergent].	Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology	2014
24157810	Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.	Cancer Letters	2014